| 注册
首页|期刊导航|世界中医药|关于急性痛风性关节炎复方中药新药临床试验设计的考虑

关于急性痛风性关节炎复方中药新药临床试验设计的考虑

周贝 吕祥 何晓红 唐健元

世界中医药2017,Vol.12Issue(9):2211-2214,4.
世界中医药2017,Vol.12Issue(9):2211-2214,4.DOI:10.3969/j.issn.1673-7202.2017.09.055

关于急性痛风性关节炎复方中药新药临床试验设计的考虑

Thoughts on Clinical Trial Design of New Compound Chinese Medicine for Acute Gouty Arthritis

周贝 1吕祥 2何晓红 3唐健元1

作者信息

  • 1. 国家食品药品监督管理总局药品审评中心,北京,100038
  • 2. 上海市中医医院国家药物临床试验机构,上海,200071
  • 3. 广东省中医院风湿科,广州,510120
  • 折叠

摘要

Abstract

Based on the thoughts on the evaluation of 6 types of new drug of compound traditional Chinese medicine for the acute gouty arthritis applied in recent years,this article made the preliminary study on the key points of the clinical trial design of TCM new drug,and also elaborated on clinical orientation,the choice of subjects,control design,treatment course and follow-up visit.The validity index selection was especially explained and discussed combined with safety index design of applied drugs containing toxic herbs and quality control of the clinical trials.

关键词

中药新药/急性痛风性关节炎/临床试验设计/考虑

Key words

New drugs of Chinese medicine/Acute gouty arthritis/Clinical trial design/Insight

分类

医药卫生

引用本文复制引用

周贝,吕祥,何晓红,唐健元..关于急性痛风性关节炎复方中药新药临床试验设计的考虑[J].世界中医药,2017,12(9):2211-2214,4.

基金项目

国家中医药管理局中医药行业科研专项(201207009) (201207009)

世界中医药

OACHSSCDCSTPCD

1673-7202

访问量0
|
下载量0
段落导航相关论文